BIOHEART-B

🇭🇰Hong Kong, China

Introduction: Shanghai Baixinan Biotechnology Co., Ltd. is a leading interventional cardiovascular device company in China. It is located in the Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. It focuses on two treatments, fully degradable stents (BRS) and renal nerve block (RDN), to address the unmet medical needs of Chinese patients with coronary and peripheral artery disease and hypertension.

The company has a leased area of about 6,500 square meters, has a clean workshop of about 40 million square meters and testing laboratories for all projects of related products, has established a quality management system that meets ISO13485/YY0287 standards, gathers professionals in machinery, materials, precision processing, clinical medicine, etc., and has a team of experienced talents in product design, quality control, clinical verification, and market development.

A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Not Applicable

Not yet recruiting

Interventions: Device: The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Locations: 🇨🇳
Beijing Anzhen Hospital Capital Medical University, Beijing, Beijing, China
🇨🇳
BeijingChao-YangHospital, Beijing, Beijing, China
🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China

Not Applicable

Locations: 🇨🇳
Tangshan Gongren Hospital, Tangshan, Hebei, China
🇨🇳
BeijingChao-YangHospital, Beijing, Beijing, China
🇨🇳
The Second Hospital of Jilin University, Changchun, Jilin, China

Not Applicable

Interventions: Device: Rapamycin Drug-Eluting Bioresorbable Coronary Stent System